Hepatitis Australia

PRINT A+ a TEXT SIZE

Legal

Use of this website and information distributed from this website is subject to the following terms of use and privacy policy. Your use of this website indicates acceptance of these terms.

You agree to follow all applicable laws when using this website. You agree you shall not upload or post unlawful, threatening, harmful, obscene, defamatory, or objectionable content, disrupt or attempt to gain unauthorised access to, transmit junk mail or comment posting, collect information about other users, sell access to the website or the data herein, or redistribute any content of this website.

You agree that all user-generated content, including but not limited to comments you leave, correspondence with its authors, participation in dynamic polls or any other form of user-submitted communication with this website is that sole property of the owner of this website. There is no expectation of confidentiality or privacy in any communications you may have with this website.

National Infoline

1300 437 222
Find the nearest hepatitis organisations
More info  >>

News

01 Feb 2012
Approval of new Hepatitis C drug Boceprevir by TGA is the first step in being considered for listing by PBAC in March
More info  >>

Our other websites

Includes information for educators, youth and your liver's health.
View more  >>
image of personal story

Consensus Statement:

Addressing Hepatitis C in Australian Custodial Settings. Despite Australian Health Ministers endorsing...
View Statement  >>
Skip to top of the page